Report Summary Catalogue Methodological

Definition and Scope:
Point of Care (POC) diagnostics and testing refer to medical diagnostic testing performed near the patient, at the point of care, rather than in a centralized laboratory setting. These tests are typically rapid, easy to use, and provide results quickly, enabling healthcare providers to make immediate treatment decisions. POC diagnostics cover a wide range of tests, including glucose monitoring, infectious disease testing, cardiac markers, and pregnancy testing. The market for POC diagnostics is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnostic tools, and the shift towards personalized medicine.
The market for POC diagnostics and testing is experiencing significant growth due to several key market trends. One major trend is the increasing adoption of POC testing in various healthcare settings, including hospitals, clinics, and home care settings. This trend is driven by the need for rapid diagnosis and treatment monitoring, especially in emergency situations. Another trend is the development of advanced technologies that enable the integration of multiple tests into a single device, providing comprehensive diagnostic capabilities in a compact and portable format. Additionally, the rising focus on preventive healthcare and the shift towards decentralized healthcare delivery models are further driving the demand for POC diagnostics.
At the same time, several market drivers are propelling the growth of the POC diagnostics market. These include the increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases, which require regular monitoring and management. The emphasis on early disease detection and intervention to improve patient outcomes and reduce healthcare costs is also fueling the demand for POC testing. Furthermore, advancements in technology, such as miniaturization, automation, and connectivity, are making POC testing more efficient, accurate, and user-friendly, contributing to market growth. Overall, the market for POC diagnostics and testing is poised for continued expansion as healthcare providers and patients alike recognize the benefits of rapid and convenient diagnostic solutions.
The global Point of Care Diagnostic and Testing market size was estimated at USD 50535.88 million in 2024, exhibiting a CAGR of 10.80% during the forecast period.
This report offers a comprehensive analysis of the global Point of Care Diagnostic and Testing market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Point of Care Diagnostic and Testing market.
Global Point of Care Diagnostic and Testing Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Point of Care Diagnostic and Testing market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Point of Care Diagnostic and Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
F. Hoffmann-La Roche
Qiagen
Danaher
Becton Dickinson and Company
Biomerieux
Siemens Healthcare
Zoetis
Abbott
Bayer
Johnson and Johnson
Nova Biomedical
Trividia Health
Quidel Corporation
Trinity Biotech
Sekisui Diagnostics
Orasure Technologies
Nipro
Spectral Medical
Market Segmentation by Type
Device
Consumables
Others
Market Segmentation by Application
Hospitals
Clinics
Home
Others
Geographic Segmentation North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Point of Care Diagnostic and Testing Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Point of Care Diagnostic and Testing Market Definition
1.2 Point of Care Diagnostic and Testing Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
2 Executive Summary
2.1 Global Point of Care Diagnostic and Testing Market Size
2.2 Market Segmentation – by Type
2.3 Market Segmentation – by Application
2.4 Market Segmentation – by Geography
3 Key Market Trends, Opportunity, Drivers and Restraints
3.1 Key Takeway
3.2 Market Opportunities & Trends
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Major Factor Assessment
4 Global Point of Care Diagnostic and Testing Market Competitive Landscape
4.1 Global Point of Care Diagnostic and Testing Sales by Manufacturers (2020-2025)
4.2 Global Point of Care Diagnostic and Testing Revenue Market Share by Manufacturers (2020-2025)
4.3 Point of Care Diagnostic and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 New Entrant and Capacity Expansion Plans
4.5 Mergers & Acquisitions
5 Global Point of Care Diagnostic and Testing Market by Region
5.1 Global Point of Care Diagnostic and Testing Market Size by Region
5.1.1 Global Point of Care Diagnostic and Testing Market Size by Region
5.1.2 Global Point of Care Diagnostic and Testing Market Size Market Share by Region
5.2 Global Point of Care Diagnostic and Testing Sales by Region
5.2.1 Global Point of Care Diagnostic and Testing Sales by Region
5.2.2 Global Point of Care Diagnostic and Testing Sales Market Share by Region
6 North America Market Overview
6.1 North America Point of Care Diagnostic and Testing Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Point of Care Diagnostic and Testing Market Size by Type
6.3 North America Point of Care Diagnostic and Testing Market Size by Application
6.4 Top Players in North America Point of Care Diagnostic and Testing Market
7 Europe Market Overview
7.1 Europe Point of Care Diagnostic and Testing Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.1.6 Sweden Market Overview
7.1.7 Denmark Market Overview
7.1.8 Netherlands Market Overview
7.1.9 Switzerland Market Overview
7.1.10 Belgium Market Overview
7.1.11 Russia Market Overview
7.2 Europe Point of Care Diagnostic and Testing Market Size by Type
7.3 Europe Point of Care Diagnostic and Testing Market Size by Application
7.4 Top Players in Europe Point of Care Diagnostic and Testing Market
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Australia Market Overview
8.1.6 Indonesia Market Overview
8.1.7 Malaysia Market Overview
8.1.8 Philippines Market Overview
8.1.9 Singapore Market Overview
8.1.10 Thailand Market Overview
8.1.11 Rest of APAC Market Overview
8.2 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Type
8.3 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Application
8.4 Top Players in Asia-Pacific Point of Care Diagnostic and Testing Market
9 South America Market Overview
9.1 South America Point of Care Diagnostic and Testing Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Point of Care Diagnostic and Testing Market Size by Type
9.3 South America Point of Care Diagnostic and Testing Market Size by Application
9.4 Top Players in South America Point of Care Diagnostic and Testing Market
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Point of Care Diagnostic and Testing Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Point of Care Diagnostic and Testing Market Size by Type
10.3 Middle East and Africa Point of Care Diagnostic and Testing Market Size by Application
10.4 Top Players in Middle East and Africa Point of Care Diagnostic and Testing Market
11 Point of Care Diagnostic and Testing Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Point of Care Diagnostic and Testing Sales Market Share by Type (2020-2033)
11.3 Global Point of Care Diagnostic and Testing Market Size Market Share by Type (2020-2033)
11.4 Global Point of Care Diagnostic and Testing Price by Type (2020-2033)
12 Point of Care Diagnostic and Testing Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Point of Care Diagnostic and Testing Market Sales by Application (2020-2033)
12.3 Global Point of Care Diagnostic and Testing Market Size (M USD) by Application (2020-2033)
12.4 Global Point of Care Diagnostic and Testing Sales Growth Rate by Application (2020-2033)
13 Company Profiles
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Overview
13.1.2 F. Hoffmann-La Roche Business Overview
13.1.3 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Major Product Offerings
13.1.4 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.1.5 Key News
13.2 Qiagen
13.2.1 Qiagen Company Overview
13.2.2 Qiagen Business Overview
13.2.3 Qiagen Point of Care Diagnostic and Testing Major Product Offerings
13.2.4 Qiagen Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.2.5 Key News
13.3 Danaher
13.3.1 Danaher Company Overview
13.3.2 Danaher Business Overview
13.3.3 Danaher Point of Care Diagnostic and Testing Major Product Offerings
13.3.4 Danaher Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.3.5 Key News
13.4 Becton Dickinson and Company
13.4.1 Becton Dickinson and Company Company Overview
13.4.2 Becton Dickinson and Company Business Overview
13.4.3 Becton Dickinson and Company Point of Care Diagnostic and Testing Major Product Offerings
13.4.4 Becton Dickinson and Company Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.4.5 Key News
13.5 Biomerieux
13.5.1 Biomerieux Company Overview
13.5.2 Biomerieux Business Overview
13.5.3 Biomerieux Point of Care Diagnostic and Testing Major Product Offerings
13.5.4 Biomerieux Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.5.5 Key News
13.6 Siemens Healthcare
13.6.1 Siemens Healthcare Company Overview
13.6.2 Siemens Healthcare Business Overview
13.6.3 Siemens Healthcare Point of Care Diagnostic and Testing Major Product Offerings
13.6.4 Siemens Healthcare Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.6.5 Key News
13.7 Zoetis
13.7.1 Zoetis Company Overview
13.7.2 Zoetis Business Overview
13.7.3 Zoetis Point of Care Diagnostic and Testing Major Product Offerings
13.7.4 Zoetis Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.7.5 Key News
13.8 Abbott
13.8.1 Abbott Company Overview
13.8.2 Abbott Business Overview
13.8.3 Abbott Point of Care Diagnostic and Testing Major Product Offerings
13.8.4 Abbott Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.8.5 Key News
13.9 Bayer
13.9.1 Bayer Company Overview
13.9.2 Bayer Business Overview
13.9.3 Bayer Point of Care Diagnostic and Testing Major Product Offerings
13.9.4 Bayer Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.9.5 Key News
13.10 Johnson and Johnson
13.10.1 Johnson and Johnson Company Overview
13.10.2 Johnson and Johnson Business Overview
13.10.3 Johnson and Johnson Point of Care Diagnostic and Testing Major Product Offerings
13.10.4 Johnson and Johnson Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.10.5 Key News
13.11 Nova Biomedical
13.11.1 Nova Biomedical Company Overview
13.11.2 Nova Biomedical Business Overview
13.11.3 Nova Biomedical Point of Care Diagnostic and Testing Major Product Offerings
13.11.4 Nova Biomedical Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.11.5 Key News
13.12 Trividia Health
13.12.1 Trividia Health Company Overview
13.12.2 Trividia Health Business Overview
13.12.3 Trividia Health Point of Care Diagnostic and Testing Major Product Offerings
13.12.4 Trividia Health Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.12.5 Key News
13.13 Quidel Corporation
13.13.1 Quidel Corporation Company Overview
13.13.2 Quidel Corporation Business Overview
13.13.3 Quidel Corporation Point of Care Diagnostic and Testing Major Product Offerings
13.13.4 Quidel Corporation Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.13.5 Key News
13.14 Trinity Biotech
13.14.1 Trinity Biotech Company Overview
13.14.2 Trinity Biotech Business Overview
13.14.3 Trinity Biotech Point of Care Diagnostic and Testing Major Product Offerings
13.14.4 Trinity Biotech Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.14.5 Key News
13.15 Sekisui Diagnostics
13.15.1 Sekisui Diagnostics Company Overview
13.15.2 Sekisui Diagnostics Business Overview
13.15.3 Sekisui Diagnostics Point of Care Diagnostic and Testing Major Product Offerings
13.15.4 Sekisui Diagnostics Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.15.5 Key News
13.16 Orasure Technologies
13.16.1 Orasure Technologies Company Overview
13.16.2 Orasure Technologies Business Overview
13.16.3 Orasure Technologies Point of Care Diagnostic and Testing Major Product Offerings
13.16.4 Orasure Technologies Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.16.5 Key News
13.17 Nipro
13.17.1 Nipro Company Overview
13.17.2 Nipro Business Overview
13.17.3 Nipro Point of Care Diagnostic and Testing Major Product Offerings
13.17.4 Nipro Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.17.5 Key News
13.18 Spectral Medical
13.18.1 Spectral Medical Company Overview
13.18.2 Spectral Medical Business Overview
13.18.3 Spectral Medical Point of Care Diagnostic and Testing Major Product Offerings
13.18.4 Spectral Medical Point of Care Diagnostic and Testing Sales and Revenue fromPoint of Care Diagnostic and Testing (2020-2025)
13.18.5 Key News
13.18.6 Key News
14 Key Market Trends, Opportunity, Drivers and Restraints
14.1 Key Takeway
14.2 Market Opportunities & Trends
14.3 Market Drivers
14.4 Market Restraints
14.5 Market Major Factor Assessment
14.6 Porter's Five Forces Analysis of Point of Care Diagnostic and Testing Market
14.7 PEST Analysis of Point of Care Diagnostic and Testing Market
15 Analysis of the Point of Care Diagnostic and Testing Industry Chain
15.1 Overview of the Industry Chain
15.2 Upstream Segment Analysis
15.3 Midstream Segment Analysis
15.3.1 Manufacturing, Processing or Conversion Process Analysis
15.3.2 Key Technology Analysis
15.4 Downstream Segment Analysis
15.4.1 Downstream Customer List and Contact Details
15.4.2 Customer Concerns or Preference Analysis
16 Conclusion
17 Appendix
17.1 Methodology
17.2 Research Process and Data Source
17.3 Disclaimer
17.4 Note
17.5 Examples of Clients
17.6 Disclaimer

Research Methodology
The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.

Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.

Research Process
The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research.
Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).